AHR and breast cancer: Importantly, AHRhigh/ALDHhigh breast cancer CSCs were significantly more efficient at initiating tumors than AHRlow/ALDHlow cells, and AHR knockdown with siRNA significantly reduced tumor-initiating capacity [162], a sine qua non of CSCs [207].